Popular Articles

Cubist Pharmaceuticals Initiates Phase 2 Trial In Europe For Therapy To Reduce Blood Loss During Surgery In High Risk Patients
Cubist Pharmaceuticals, Inc. (Nasdaq: CBST), a leading acute care therapeutics company, announced that it has begun dosing in the CONSERV™-2 clinical trial with ecallantide. CONSERV-2, being conducted in Europe, is a Phase 2 trial that will investigate ecallantide"s effect on surgical blood loss volume in cardiac surgery patients who are on cardiopulmonary bypass and are at a high risk of bleeding. The trial is expected to enroll 300 subjects.
generic viagra online
Building A Better Blend Of Tumor-Fighting Cells
Israeli researchers have developed a technique that could produce a more effective blend of tumor-fighting immune cells used to treat cancers such as metastatic melanoma.
News of the day
Does Mom Know When Enough Is Enough?
As the childhood obesity epidemic in the United States continues, researchers are examining whether early parent and child behaviors contribute to the problem. A study from the Department of Nutritional Sciences, Rutgers University, published in the May/June 2009 issue of the Journal of Nutrition Education and Behavior reports that mothers who miss signs of satiety in their infants tend to overfeed them, leading to excess weight gains during the 6 month to 1 year period.
Medical Devices

Chicago Public Schools To Launch Education, Treatment Program To Curb Chlamydia, Gonorrhea

The Chicago Public Schools system this year will launch a pilot program to provide students in grades 11 and 12 with voluntary education, testing and treatment for chlamydia and gonorrhea, the Chicago Sun-Times reports. The Chicago Department of Public Health will administer the program at six Cook County, Ill., schools at no cost to the school system.According to the Sun-Times, Centers for Disease Control and Prevention data from 2007 -- the most recent year available -- showed that Cook County had the second-highest number of reported chlamydia cases in the U.S. at 583 cases per 100,000 people, or 30,881 total cases. In addition, the county rated first in the nation for reported gonorrhea cases at 233 per 100,000 people, or 12,338 total cases.Christopher Brown, assistant commissioner of the health department, said, "It"s a very large problem with teens and adolescents in Chicago, and it"s very, very important that they get the information about these sexually transmitted infections." He added, "Our goal is to get the information out to teens -- about how they"re transmitted in particular -- and also that there"s treatment available."The six schools have yet to be selected, and they may opt not to participate if chosen, the Sun-Times reports. To qualify, schools must have their own health centers. Monique Bond, a spokesperson for CPS, said that the health centers will administer the testing and provide treatment to students with the STIs (Ihejirika, Chicago Sun-Times, 6/26). Reprinted with kind permission from http://www.nationalpartnership.org. You can view the entire Daily Women"s Health Policy Report, search the archives, or sign up for email delivery here. The Daily Women"s Health Policy Report is a free service of the National Partnership for Women & Families, published by The Advisory Board Company. © 2009 The Advisory Board Company. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):